Insider Trading & SAST disclosures for Vista Pharmaceuticals Ltd.
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
Dhananjaya Alli in Vista Pharmaceuticals Ltd. where Acquisition of 1,007,391
Equity Shares done at an average price of Rs. 2
was reported to the exchange on Aug. 5, 2021.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Kamal Gadalay & PACs in Vista Pharmaceuticals Ltd. where Acquisition of 52,625
shares done
was reported to the exchange on Dec. 22, 2022.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
Kamal Gadalay & PACs
|
Other |
Acquisition |
27 Dec 2022 |
52,625 |
1,661,818
(4.52%)
|
0.14%
|
|
-
|
20 Dec 2022 21 Dec 2022 |
SAST (29(2)) |
- |
Market |
Suresh Gadaley & PACs
|
Other |
Acquisition |
27 Dec 2022 |
50,000 |
4,300,826
(11.69%)
|
0.13%
|
|
-
|
21 Dec 2022 21 Dec 2022 |
SAST (29(1)) |
- |
Market |
Dhananjaya Alli
|
KMP |
Acquisition |
05 Aug 2021 |
1,007,391 |
3,837,424
(10.43%)
|
2.74%
|
2 |
2,014,782
|
26 Jul 2021 26 Jul 2021 |
Insider Trading |
Equity Shares |
Gift |
Bojja Sreenivasulu
|
Other |
Disposal |
31 Jul 2021 |
1,007,391 |
-
|
2.74%
|
|
-
|
26 Jul 2021 26 Jul 2021 |
SAST (29(2)) |
- |
Market |
Dhananjaya Alli
|
Promoter |
Acquisition |
31 Jul 2021 |
1,007,391 |
3,837,424
(10.43%)
|
2.74%
|
|
-
|
26 Jul 2021 26 Jul 2021 |
SAST (29(2)) |
- |
Market |
Dhananjaya Alli
|
KMP |
Acquisition |
22 Mar 2021 |
1,400,000 |
2,830,033
(7.69%)
|
3.80%
|
2 |
2,800,000
|
19 Mar 2021 19 Mar 2021 |
Insider Trading |
Equity Shares |
Gift |
Dhananjay Alli
|
Promoter |
Acquisition |
22 Mar 2021 |
1,400,000 |
2,830,033
(7.69%)
|
3.80%
|
|
-
|
19 Mar 2021 19 Mar 2021 |
SAST (29(2)) |
- |
Market |
Bojja Sreenivasulu
|
Other |
Disposal |
23 Mar 2021 |
1,400,000 |
1,007,391
(2.74%)
|
3.80%
|
|
-
|
19 Mar 2021 19 Mar 2021 |
SAST (29(2)) |
- |
Market |
Anand Chittajallu
|
Other |
Acquisition |
07 Aug 2020 |
1,428,570 |
1,428,570
(3.88%)
|
3.88%
|
|
-
|
03 Aug 2020 03 Aug 2020 |
SAST (29(1)) |
- |
Pref. Allotment |
Umakanth Katta
|
Other |
Acquisition |
06 Aug 2020 |
2,857,144 |
5,000,000
(13.58%)
|
7.76%
|
|
-
|
03 Aug 2020 03 Aug 2020 |
SAST (29(1)) |
- |
Pref. Allotment |
Anand Chittajallu
|
Director |
Acquisition |
06 Aug 2020 |
1,428,570 |
1,428,570
(3.88%)
|
4.70%
|
2 |
2,857,140
|
03 Aug 2020 03 Aug 2020 |
Insider Trading |
Equity Shares |
Allotment |
Umakanth Katta
|
Director |
Acquisition |
06 Aug 2020 |
2,857,144 |
5,000,000
(13.59%)
|
9.41%
|
2 |
5,714,288
|
03 Aug 2020 03 Aug 2020 |
Insider Trading |
Equity Shares |
Allotment |
Umakanth Katta
|
Other |
Acquisition |
15 Jul 2020 |
1,071,428 |
2,142,856
(6.59%)
|
3.29%
|
|
-
|
13 Jul 2020 13 Jul 2020 |
SAST (29(1)) |
- |
Pref. Allotment |
Umakanth Katta
|
Director |
Acquisition |
15 Jul 2020 |
1,071,428 |
2,142,856
(6.59%)
|
3.53%
|
2 |
2,142,856
|
13 Jul 2020 13 Jul 2020 |
Insider Trading |
Equity Shares |
Allotment |
UmakanthKatta
|
Other |
Acquisition |
09 Jul 2020 |
1,071,428 |
1,071,428
(3.40%)
|
3.40%
|
|
-
|
07 Jul 2020 07 Jul 2020 |
SAST (29(1)) |
- |
Pref. Allotment |
Vasant V Alli
|
Promoter |
Acquisition |
08 Feb 2019 |
190,574 |
1,601,478
(5.27%)
|
0.63%
|
|
-
|
06 Feb 2019 06 Feb 2019 |
SAST (29(1)) |
- |
Pref. Allotment |
Vasant V Alli
|
Promoter |
Acquisition |
25 Jan 2019 |
189,851 |
1,410,904
(4.68%)
|
0.65%
|
37.5 |
7,119,412.50
|
24 Jan 2019 24 Jan 2019 |
Insider Trading |
Equity Shares |
Conv. of Warrants |
Vasant V Alli
|
Promoter |
Disposal |
25 Jan 2019 |
189,851 |
472,429
|
0.65%
|
37.5 |
7,119,412.50
|
24 Jan 2019 24 Jan 2019 |
Insider Trading |
Convertible Warrants |
Conv. of Warrants |
Vasant V Alli
|
Promoter |
Acquisition |
25 Jan 2019 |
189,851 |
1,410,904
(4.68%)
|
0.63%
|
|
-
|
24 Jan 2019 24 Jan 2019 |
SAST (29(1)) |
- |
Pref. Allotment |
Vasant V Alli
|
Promoter |
Disposal |
30 Dec 2018 |
837,720 |
662,280
|
2.87%
|
|
-
|
26 Dec 2018 26 Dec 2018 |
Insider Trading |
Convertible Warrants |
Pref. Allotment |
Vasant V Alli
|
Promoter |
Acquisition |
30 Dec 2018 |
837,720 |
1,221,053
(4.07%)
|
2.87%
|
37.5 |
31,400,000
|
|
Insider Trading |
Equity Shares |
Pref. Allotment |
Vasant V Alli
|
Promoter |
Acquisition |
28 Dec 2018 |
837,720 |
1,221,053
(4.07%)
|
2.79%
|
|
-
|
26 Dec 2018 26 Dec 2018 |
SAST (29(1)) |
- |
Pref. Allotment |
Vasant V Alli
|
Promoter |
Acquisition |
30 Nov 2017 |
1,500,000 |
1,500,000
|
5.15%
|
12.5 |
18,750,000
|
28 Nov 2017 28 Nov 2017 |
Insider Trading |
Convertible Warrants |
Pref. Allotment |
Keshava Murthy Shiva Shankar
|
Other |
Disposal |
18 Sep 2017 |
900,500 |
1,705,158
(5.95%)
|
3.14%
|
|
-
|
14 Sep 2017 14 Sep 2017 |
SAST (29(2)) |
- |
Market |
Dhananjaya Alli
|
Promoter & Director |
Disposal |
01 Aug 2017 |
511,561 |
1,770,000
|
1.76%
|
24.1 |
12,303,043
|
28 Jul 2017 28 Jul 2017 |
Insider Trading |
Convertible Warrants |
Conv. of Warrants |
Dhananjaya Alli
|
Promoter & Director |
Acquisition |
01 Aug 2017 |
511,561 |
1,430,033
(4.99%)
|
1.76%
|
24.1 |
12,303,043
|
28 Jul 2017 28 Jul 2017 |
Insider Trading |
Equity Shares |
Conv. of Warrants |
Vista Pharmaceuticals Inc
|
Promoter |
Disposal |
01 Aug 2017 |
211,000 |
832,808
|
0.72%
|
24.1 |
5,074,550
|
28 Jul 2017 28 Jul 2017 |
Insider Trading |
Convertible Warrants |
Conv. of Warrants |
Dhananjaya Alli
|
Promoter |
Acquisition |
01 Aug 2017 |
511,561 |
1,430,033
(4.99%)
|
1.79%
|
|
-
|
19 Jul 2017 19 Jul 2017 |
SAST (29(1)) |
- |
Pref. Allotment |
Vista Pharmaceuticals Inc
|
Promoter |
Acquisition |
01 Aug 2017 |
211,000 |
6,579,620
(22.97%)
|
0.74%
|
|
-
|
28 Jul 2017 28 Jul 2017 |
SAST (29(2)) |
- |
Pref. Allotment |
Vista Pharmaceuticals Inc
|
Promoter |
Acquisition |
01 Aug 2017 |
211,000 |
6,579,620
(22.97%)
|
0.72%
|
24.1 |
5,074,550
|
28 Jul 2017 28 Jul 2017 |
Insider Trading |
Equity Shares |
Conv. of Warrants |
Dhananjaya Alli
|
Promoter |
Acquisition |
11 Jul 2017 |
768,439 |
918,472
(3.29%)
|
2.75%
|
|
-
|
07 Jul 2017 07 Jul 2017 |
SAST (29(1)) |
- |
Pref. Allotment |
Vista Pharmaceuticals Inc
|
Promoter |
Acquisition |
11 Jul 2017 |
356,192 |
6,368,620
(22.81%)
|
1.28%
|
|
-
|
07 Jul 2017 07 Jul 2017 |
SAST (29(2)) |
- |
Pref. Allotment |
Vista Pharmaceuticals Inc Revised
|
Promoter |
Disposal |
11 Jul 2017 |
356,192 |
1,043,808
|
1.22%
|
24.1 |
8,566,418
|
07 Jul 2017 07 Jul 2017 |
Insider Trading |
Convertible Warrants |
Conv. of Warrants |
Vista Pharmaceuticals Inc Revised
|
Promoter |
Acquisition |
11 Jul 2017 |
356,192 |
6,368,620
(22.81%)
|
1.22%
|
24.1 |
8,566,418
|
07 Jul 2017 07 Jul 2017 |
Insider Trading |
Equity Shares |
Conv. of Warrants |
Dhananjaya Alli Revised
|
Promoter & Director |
Disposal |
11 Jul 2017 |
768,439 |
2,281,561
|
2.64%
|
24.1 |
18,480,958
|
07 Jul 2017 07 Jul 2017 |
Insider Trading |
Convertible Warrants |
Conv. of Warrants |
Dhananjaya Alli Revised
|
Promoter & Director |
Acquisition |
11 Jul 2017 |
768,439 |
918,472
(3.29%)
|
2.64%
|
24.1 |
18,480,958
|
07 Jul 2017 07 Jul 2017 |
Insider Trading |
Equity Shares |
Conv. of Warrants |
Vista Pharmaceuticals Inc
|
Promoter |
Acquisition |
17 Apr 2017 |
78,714 |
6,012,428
(22.43%)
|
0.27%
|
24.1 |
1,893,071.70
|
13 Apr 2017 13 Apr 2017 |
Insider Trading |
Equity Shares |
Pref. Allotment |
Vista Pharmaceuticals Inc
|
Promoter |
Acquisition |
17 Apr 2017 |
78,714 |
6,012,428
(22.43%)
|
0.29%
|
|
-
|
13 Apr 2017 13 Apr 2017 |
SAST (29(2)) |
- |
Pref. Allotment |
Dhananjaya Alli
|
Promoter |
Acquisition |
17 Apr 2017 |
150,000 |
150,033
(0.56%)
|
0.56%
|
|
-
|
13 Apr 2017 13 Apr 2017 |
SAST (29(1)) |
- |
Pref. Allotment |
Dhananjaya Alli
|
Promoter & Director |
- |
17 Apr 2017 |
3,050,000 |
3,050,000
|
10.46%
|
|
-
|
13 Apr 2017 13 Apr 2017 |
Insider Trading |
- |
Pref. Allotment |
Dhananjaya Alli
|
Promoter & Director |
Acquisition |
17 Apr 2017 |
150,000 |
150,033
(0.56%)
|
0.51%
|
24.1 |
3,607,500
|
13 Apr 2017 13 Apr 2017 |
Insider Trading |
Equity Shares |
Pref. Allotment |
Vista Pharmaceuticals Inc
|
Promoter |
- |
17 Apr 2017 |
1,400,000 |
1,400,000
|
4.80%
|
|
-
|
13 Apr 2017 13 Apr 2017 |
Insider Trading |
- |
Pref. Allotment |
Vista Pharmaceuticals Inc
|
Promoter |
Acquisition |
03 Apr 2017 |
1,571,286 |
5,933,714
(22.33%)
|
5.91%
|
|
-
|
31 Mar 2017 31 Mar 2017 |
SAST (29(2)) |
- |
Pref. Allotment |
Vista Pharmaceuticals Inc
|
Promoter |
Acquisition |
03 Apr 2017 |
1,571,286 |
5,933,714
(22.33%)
|
5.39%
|
24.0 |
37,789,428.30
|
31 Mar 2017 31 Mar 2017 |
Insider Trading |
Equity Shares |
Pref. Allotment |
Pradeep Kumar Samala
|
Other |
Disposal |
06 Mar 2017 |
1,900,000 |
771,666
(3.09%)
|
7.60%
|
|
-
|
03 Mar 2017 03 Mar 2017 |
SAST (29(2)) |
- |
Market |
Pradeep Kumar Samala
|
Other |
Acquisition |
06 Mar 2017 |
2,671,666 |
2,671,666
(10.69%)
|
10.69%
|
|
-
|
02 Mar 2017 03 Mar 2017 |
SAST (29(1)) |
- |
Off Market |
Gopal Dasari
|
Other |
Disposal |
06 Mar 2017 |
2,671,666 |
-
|
10.69%
|
|
-
|
02 Mar 2017 03 Mar 2017 |
SAST (29(2)) |
- |
Off Market |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.